Del 211 - Handbook of Clinical Neurology

Cholinergic Involvement in Neurodegenerative Diseases

Inbunden, Engelska, 2025

Av A. Claudio Cuello, Canada) Cuello, A. Claudio (Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, A Claudio Cuello

2 899 kr

Beställningsvara. Skickas inom 5-8 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

Cholinergic Involvement in Neurodegenerative Diseases, Volume 211 reviews cholinergic function in the brain as it relates to Neurodegenerative disorders. Coverage includes Alzheimer’s, dementia, Down Syndrome, Parkinson’s, Huntington’s, ALS, and more. In addition, the anatomy of the cholinergic system is described as well as the distribution and function of receptors.

Discusses the cholinergic system as it relates to neurodegenerative diseases
Encompasses broad, comprehensive content on dementia, Alzheimer’s, Parkinson’s, Huntington’s, ALS and more
Covers anatomy and the distribution/function of receptors

Produktinformation

Utgivningsdatum2025-06-05
Mått216 x 276 x 20 mm
Vikt907 g
FormatInbunden
SpråkEngelska
SerieHandbook of Clinical Neurology
Antal sidor268
FörlagElsevier Science
ISBN9780443190889

Tillhör följande kategorier

Biovetenskap inom Naturvetenskap och teknik
Neurologi och klinisk neurofysiologi inom Medicin
Patologi inom Medicin

1. The history of the CNS cholinergic transmission2. Organization of the basal forebrain cholinergic system in the human brain3. The cholinergic synapses4. Nicotinic acetylcholine receptors in the brain5. Cognition and modulation of the cholinergic system6. The involvement of the cholinergic system in Alzheimer disease7. Structural changes to the basal forebrain cholinergic system in the continuum of the Alzheimer’s pathology8. The dependence of basal forebrain cholinergic neurons on NGF: The case in Alzheimer pathology9. NGF based cholinergic therapies in Alzheimer disease10. Memory network and cognitive reserve are associated with preserved and stimulated cholinergic neurotransmission11. Cholinergic therapy in Alzheimer’s disease12. CNS muscarinic receptors agonists in Alzheimer’s disease treatment13. The Cholinergic system in down syndrome14. The Cholinergic system in Parkinson disease15. The Cholinergic system in dementia with Lewy bodies16. Epilogue. Standing on the shoulders of giants—Charting the future of cholinergic research